Enfusion (ENFN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 revenue reached $51.2 million, up 15.4% year-over-year, driven by up-market strategy, new product rollouts, and client expansion, with 38 new clients added for a total of 894.
Record annualized contract value (ACV) of $229,000, up 5.7% year-over-year, and notable wins in the Americas, EMEA, and APAC, including Agile Investment Management, Frontier Global Partners, and a $500M AUM Hong Kong manager.
Growth was driven by upsell, increased users within existing contracts, new client revenue, and full-period impact of prior contracts.
Product initiatives and talent upgrades expanded the addressable market and improved service for larger clients, with geographic diversification and wins in 12 countries.
Operating as a single reportable segment, with continued investment in technology and development to expand the SaaS platform.
Financial highlights
Q3 2024 total revenue: $51.2 million (+15.4% YoY); gross profit: $34.8 million (68.1% margin); adjusted gross profit: $35.2 million (68.8% margin).
Adjusted EBITDA: $11.1 million (21.8% margin); adjusted net income: $5.9 million (EPS $0.05); GAAP net income: $2.0 million (EPS $0.02).
Adjusted free cash flow: $13.7 million (123% conversion); net cash from operating activities for nine months: $25.0 million, up 31.3% year-over-year.
Cash and cash equivalents were $48.3 million as of September 30, 2024, with no debt and $99.9 million in available borrowing capacity.
Operating expenses rose 17.2% to $31.8 million, mainly due to higher stock-based compensation, payroll, and professional fees.
Outlook and guidance
Full-year 2024 revenue guidance narrowed to $202–$205 million; adjusted EBITDA guidance to $41–$45 million, with a midpoint margin of 21.1%.
Medium-term (2025–2027) guidance: annual revenue growth of 20–22%, adjusted EBITDA margin expansion of 200–400 bps, and FCF conversion expansion of 300–500 bps.
Reiterated free cash flow conversion guidance of 50–55%.
Management expects continued investment in technology and development to drive future growth.
Current liquidity and available credit are expected to be sufficient to fund operations and capital needs for at least the next 12 months.
Latest events from Enfusion
- Q2 revenue up 16% with margin expansion, strong client wins, and reaffirmed guidance.ENFN
Q2 20242 Feb 2026 - Unified SaaS platform targets asset manager growth, aiming for Rule of 40 via higher-value contracts.ENFN
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q4 revenue up 13.9% year-over-year; Clearwater Analytics acquisition pending.ENFN
Q4 20245 Jun 2025